Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut

Gut. 2024 Jun 6;73(7):1214-1215. doi: 10.1136/gutjnl-2023-329792.
No abstract available

Keywords: ANTIBIOTICS; COLONIC MICROFLORA; DRUG RESISTANCE; HELICOBACTER PYLORI.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Clarithromycin* / administration & dosage
  • Clarithromycin* / therapeutic use
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination*
  • Gastrointestinal Microbiome* / drug effects
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori* / drug effects
  • Humans
  • Proton Pump Inhibitors / administration & dosage

Substances

  • Clarithromycin
  • Anti-Bacterial Agents
  • Proton Pump Inhibitors